Lexicon Pharmaceuticals, Inc. (LXRX) vs Rigel Pharmaceuticals, Inc. (RIGL)

Lexicon Pharmaceuticals, Inc. and Rigel Pharmaceuticals, Inc. are both Biotechnology companies. Lexicon Pharmaceuticals, Inc. and Rigel Pharmaceuticals, Inc. are of similar size ($894.6M and $854.3M). Lexicon Pharmaceuticals, Inc. has negative trailing earnings, so its P/E is not meaningful; Rigel Pharmaceuticals, Inc. trades at 2.7×. Rigel Pharmaceuticals, Inc. grew revenue faster over the last twelve months: 3.31% against −29.0%. Rigel Pharmaceuticals, Inc. has the higher net margin (116.3% vs −147.4%) and the higher return on invested capital (16.5% vs −96.4%). Across the 18 metrics below, Rigel Pharmaceuticals, Inc. leads on 16 and Lexicon Pharmaceuticals, Inc. on 2.